Bleeding News and Research

RSS

Research uncovers a new way to boost the effectiveness of RNA therapies

Investigators from the Smidt Heart Institute at Cedars-Sinai have identified how biological pacemaker cells - cells that control your heartbeat - can "fight back" against therapies to biologically correct abnormal heartbeat rates.

20 Dec 2022

Psychosocial stress linked with increased risk of stroke

Psychosocial stress is associated with an increased risk of stroke, according to new University of Galway led research published in the Journal of the American Medical Association Network Open (JAMA Network Open).

19 Dec 2022

No benefit of low dose apixaban following acute COVID-19

The HEAL-COVID trial compared the efficacy of Apixaban to standard care in adults who have recently recovered from severe COVID-19.

14 Dec 2022

Strong connection between inflammatory bowel disease and periodontitis

Inflammatory bowel disease often coexists with periodontal disease. This is shown by new publications from a European research project that explored the connection between the two diseases.

13 Dec 2022

Simplified treatment regimen results in dramatic decrease in early deaths from acute promyelocytic leukemia

The use of a simplified treatment regimen by oncologists, along with management recommendations and 24/7 support provided by a limited and dedicated group of academic disease experts, resulted in a dramatic decrease in early deaths from acute promyelocytic leukemia (APL).

12 Dec 2022

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

For people ages 75 and older, age-related changes in general health and in the heart and blood vessels require consideration and likely modifications in how heart attacks and heart disease are treated, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

12 Dec 2022

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.

12 Dec 2022

ASCOT trial pinpoints most efficient level of blood thinning treatment for hospitalized COVID-19 patients

The COVID-19 global pandemic remains a major public health challenge. ASCOT researchers aim to discover which treatments are most effective in patients hospitalized with COVID-19.

12 Dec 2022

Liver cancer study could help improve the safety of certain gene therapies for hemophilia

Research led by Randal J. Kaufman, Ph.D., has found that misfolded proteins in liver cells contribute to the development of liver cancer, shedding new light on the mysterious origins of one of the world's deadliest diseases.

7 Dec 2022

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Dr Arturo Reyes Sandoval is the Director of the National Polytechnic Institute, one of the largest and most prestigious universities in Mexico.

7 Dec 2022

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

The Pfizer-BioNTech mRNA-based COVID-19 vaccine may increase the risk of menstrual disturbances in adolescent girls in their first cycle after vaccination.

6 Dec 2022

Study on mpox epidemiology in New York during summer 2022

Researchers presented a summary of their experience of identifying, managing, and vaccinating monkeypox (MPX) virus (MPXV)-infected individuals in New York during the summer season of 2022.

30 Nov 2022

Oral anticoagulant does not help patients recovering from moderate and severe COVID-19

A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke's Hospital and the University of Cambridge has found.

28 Nov 2022

Bleeding News and Research

Research uncovers a new way to boost the effectiveness of RNA therapies

Psychosocial stress linked with increased risk of stroke

No benefit of low dose apixaban following acute COVID-19

Strong connection between inflammatory bowel disease and periodontitis

Simplified treatment regimen results in dramatic decrease in early deaths from acute promyelocytic leukemia

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

ASCOT trial pinpoints most efficient level of blood thinning treatment for hospitalized COVID-19 patients

Liver cancer study could help improve the safety of certain gene therapies for hemophilia

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

Study on mpox epidemiology in New York during summer 2022

Oral anticoagulant does not help patients recovering from moderate and severe COVID-19

Additional six weeks of anti-clotting treatment reduces further clot risk after distal DVT

Using warmer brain-irrigation fluid can reduce repeat operations to remedy subdural hematoma

Acupuncture significantly improves lower back or pelvic pain during pregnancy

New method can protect organs during heart and aortic surgery

Scientists develop new injectable hydrogel for treatment of aneurysms

First transfusions of lab-grown blood

Scientists investigate whether FSAP protein could be used as a treatment for stroke

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News